New Asprin in Trinity School of Pharmacy

New Molecule Added

New Molecule Added

Trinity School of Pharmacy have been working on a new form of Aspirin.
Aspirin , by nature, has been used as a preventative action against heart attacks, blood clots and strokes, but the acidic ingredients have been known to lead to stomach ulcers and bleeding. The dominant cause of this is the active aspirin ingredient dissolving prior to hitting the blood stream.
Trinity have been working on a counter to this. Trinity Scientist John Gilmer has been working on adding a new molecule which deactivates the asprin until it enters the bloodstream, hence protecting the stomach and small intestine.

Dr Gilmer is now collaboratring with colleagues Prof Marek Radomski (platelet biolody) and Dr Carlos Medina (gasteroenterologist) to take the drug to the next step of clinical trials.

Trials for this new Aspirin are expected to occour in Ireland at the end of 2011.

R&D at UCD

R&D

R&D

The preeminence of R&D at UCD is very much in evidence and globally renown. Despite the shortcomings of the current government and its recent track record on the economy, its long term investment  strategy in relation to R&D appears to be on target. €14.8m is being invested over the next five years in the Systems Biology Ireland Research Centre and will be centered at the UCD campus, already home to NIBRT, (National Institute for Bioprocessing Research and Training).

It is hoped that this will make Ireland a leader in the consolidation of computing, maths and biology and will further enhance Ireland’s attractiveness as a site of  foreign direct investment for the future as this state of the art computing center will considerably promote Ireland as a significant R&D center of expertise and scientific research in addition to being a major scientific contributor in the fight against cancer and various other life threatening medical conditions

Adding  to the attractiveness of  NIBRT’s direct industrial applications and capabilities potential, the consolidation of computer modeling and study of biological systems offers a similar appeal to R&D clients. Collectively these  will present considerable marketing advantages for Ireland as a center for foreign direct investment and offers enhanced potential  for collaborative projects which can only improve Ireland’s already excellent reputation for world class scientific and engineering professionalism. 

For more news on developments and employment opportunities in science and technolgy in Ireland, please visit our news and jobs pages